BridgeBio Pharma, Inc. (BBIO) Stock buybacks 2020–2025
BridgeBio Pharma, Inc. (BBIO) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$48.3MFY2025 · since FY2020: $75.0M → $48.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $48.3M | — |
| FY2024 | $0 | — |
| FY2023 | $0 | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $200.0M | +166.7% |
| FY2020 | $75.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice